Meta-Analysis to Identify And Evaluate Factors Associated With Regulatory Approval of Orphan Drugs (Od) to Develop an Algorithm For Predicting Regulatory Approval (Success) And to Develop A Standardized Tool to Improve Orphan Drug Portfolio Decision-Making